Live Markets  BS Home News Now Markets & Investing Companies & Industry  Portfolio MON 23 NOV, 2009 09:29 AM FEEDBACK 
  Live Markets* > Company Details
Get Quote Search
Stock Quote Cipla Ltd
BSE: Rs 308.95   4.4 (1.44%)
November,20 04:01
NSE: Rs 308.8   0 (0.00%)
November,20 03:59
Sensex
BSENSE
 
Cipla Ltd
Sector Gainers
Sector Losers
CompanyLast (Rs)Gain (%)
Titan BioTech25.7010.30
Inwinex Pharma.4.534.86
Saamya Biotech6.704.85
Natco Pharma114.204.48
Mangalam Drugs11.854.22
Welcure Drugs2.673.09
Bal Pharma26.252.94
Glenmark Pharma.254.102.94
(Source: BSE)
 more  
 Financials Results (Quarterly)
 Particulars (Rs lakh) Sep-09 Jun-09
 Sale144288137604
 Other Income12821197
 Total expenses106204103452
 Net profit2757424171
 Equity1605815546
 more  
(Source: BSE)
  Broker Calls
Report Name Broker Name Reco Price View
Cipla Indiabulls Hold 277.1
Cipla Angel Broking Reduce 261
Cipla Angel Broking Reduce 275
Cipla Angel Broking Reduce 244
Cipla Angel Broking Accumulate 187
Cipla BRICS Buy 173
Cipla Angel Broking Neutral 226
Cipla Indiabulls Hold 208.4
Cipla Angel Broking Neutral 224
  Returns (%) more 
Particulars BSE(%) NSE(%) 
One month8.358.43
Six months42.7042.61
One year67.2768.03
(Source: BSE)
 
BSE: 500087 | NSE: CIPLA
 BSENSE
Open 304.55 304.10
Day High 310.10 310.80
Day Low 302.10 303.00
Previous Close 304.55 308.75
52-Week high 313.70 314.00
52-Week low 172.00 171.35
P/E 32.17 32.15
Market Cap (Rs cr) 24805.6 24789.54
Volume 326214.00 1570372.00
 Peer Group
Company Last (Rs) Mkt Cap (Rs cr)
Ranbaxy Labs. 422.45 17758
Sun Pharma.Inds. 1437.00 29763
Biocon 267.90 5358
Cadila Health. 570.85 7792
Piramal Health 400.85 8378
Glenmark Pharma. 254.10 6368
(Source: BSE)
 Company Profile - Cipla
Profile
Chairman & Managing Director: Dr Y K Hamied
Email: cosecretary@cipla.com
Site Url: www.cipla.com
Company Address
289 J B B Marg Bellasis Road
Mumbai Central
Mumbai
Phone: 91-022-23023272/23082891/95521
Fax: 91-022-23008101/23070013/393/8
 
  Cipla News more 
Cipla launches generic drug to treat H1N1
Mankind vs Goliaths
Cipla to launch ayurveda and homeo products in India
Forex gains push Cipla Q2 net up 82%
Vivimed Labs in Rs 130-cr expansion
Rally prompts promoters to sell treasury stock
Cipla to offload 4% stake for Rs 840 crore
  Performance & Analysis more 
ParticularsBSENSE
EPS (Trailing 12 mnths,Rs)12.3812.38
Free Float (%)61.8761.87
FII holding 16.2916.29
ROCE(%)18.0518.05
Face Value (in Rs) 2.00
  Shareholding Pattern more 
ParticularsMar-08Dec-07
Indian promoters17.9317.93
Foreign promoters21.4521.45
Acting person--
Other promoters--
MFs/UTI1.341.80
Banks/FIs11.7111.65
FIIs18.3316.66
Public corporate bodies1.141.47
Indian public23.8424.78
NRIs/OCBs--
Others3.563.56
No of shares777291357777291357
(Source: BSE)
  
Quick Links
Market News Commodities News
Top Gainers Top Losers
52 Week High 52 Week Low
The Smart Investor Broker calls
BSE Notices IPO
 
Stock Name A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
 
Business Standard Network:  Business Standard.com | BSmotoring.com | BShindi.com | E-paper | Portfolios
ABOUT US PARTNER WITH US JOBS@BS ADVERTISE WITH US TERMS & CONDITIONS SITE MAP CONTACT US
Business Standard Ltd. Copyright & Disclaimer feedback@business-standard.com
This site is best viewed with Internet Explorer 6.0 or higher; Firefox 2.0 or higher at a minimum screen resolution of 1024x768
* Stock quotes delayed by 10 minutes or more. All information provided is on "as is" basis and for information purposes only. Kindly consult your financial advisor or stock broker to verify the accuracy and recency of all the information prior to taking any investment decision. While due diligence is done and care taken prior to uploading the stock price data, neither Business Standard Limited, www.business-standard.com nor any independent service provider is/are liable for any information errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.